Brief: Charmacy Pharmaceutical Says HY Net Profit Attributable Down 20.50%
31/08/2022 14:51
Aug 31 (Reuters) - Charmacy Pharmaceutical Co Ltd 2289.HK :
* HY NET PROFIT ATTRIBUTABLE RMB20.6 MILLION, DOWN 20.50%
* HY OPERATING REVENUE RMB1.89 BILLION VERSUS RMB1.99
BILLION
Source text for Eikon: ID:nHKSXJKyn
Further company coverage: 2289.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Charmacy Pharmaceutical Co
See all newsBrief: Charmacy Pharmaceutical Sees Decrease In Net Profit Attributable By 45% For Year
Brief: Charmacy Pharmaceutical Says Yao Chuanglong Ceased To Be Chairman
Brief: Charmacy Pharmaceutical Posts FY Operating Revenue RMB4,175.28 Million
Brief: Charmacy Pharmaceutical Says Controlling Shareholder To Provide Loan Facility
Brief: Charmacy Pharmaceutical Says Applied For Trading Resumption From Feb 17